Free Trial

HLS Therapeutics (HLS) Insider Trading & Ownership

HLS Therapeutics logo
C$3.62 +0.02 (+0.56%)
(As of 05:28 PM ET)

HLS Therapeutics (TSE:HLS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.37%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
C$17,903.00
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
C$1,655.00
Get HLS Insider Trade Alerts

Want to know when executives and insiders are buying or selling HLS Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

HLS Insider Buying and Selling by Quarter

HLS Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/12/2024John Lee Welborn Jr.DirectorBuy2,100C$3.25C$6,825.00
11/14/2024Norma BeauchampDirectorSell500C$3.31C$1,655.00
8/14/2024John Gordon HannaDirectorBuy1,200C$3.19C$3,828.00
5/15/2024Craig MillianDirectorBuy2,500C$2.90C$7,250.00
(Data available from 1/1/2013 forward)

HLS Insider Trading Activity - Frequently Asked Questions

The list of insiders at HLS Therapeutics includes Brian Thomas Walsh, Craig Millian, John Gordon Hanna, John Lee Welborn Jr., Norma Beauchamp, Polar Asset Management Partners Inc., Tim Hendrickson, and William M. Wells. Learn more on insiders at HLS.

0.37% of HLS Therapeutics stock is owned by insiders. Learn more on HLS's insider holdings.

The following insiders have purchased HLS shares in the last 24 months: Brian Thomas Walsh (C$2,910.00), Craig Millian (C$20,250.00), John Gordon Hanna (C$3,828.00), John Lee Welborn Jr. (C$6,825.00), Polar Asset Management Partners Inc. (C$86,000.00), and Tim Hendrickson (C$11,250.00).

Insiders have purchased a total of 34,300 HLS shares in the last 24 months for a total of C$131,063.00 bought.

The following insider sold HLS shares in the last 24 months: Norma Beauchamp (C$1,655.00).

Insiders have sold a total of 500 HLS Therapeutics shares in the last 24 months for a total of C$1,655.00 sold.

HLS Therapeutics Key Executives

  • Mr. Craig Stuart Millian M.B.A. (Age 56)
    CEO & Director
    Compensation: $941.87k
  • Mr. John Hanna C.P.A. (Age 59)
    CGA, M.B.A., Interim CFO & Non-Independent Director
    Compensation: $42.34k
  • Dr. Jason A. Gross Pharm.D. (Age 59)
    Vice President of Scientific Affairs
    Compensation: $361.8k
  • Mr. Ryan C. Lennox B.A. (Age 43)
    J.D., Senior VP of Legal, HR & Compliance and Corporate Secretary
    Compensation: $434.18k
  • Mr. Brian T. Walsh
    Senior Vice President of Commercial
  • Mr. David Spence (Age 56)
    VP & Corporate Controller


This page (TSE:HLS) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners